U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H16N5O13P3
Molecular Weight 507.181
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZIDOVUDINE TRIPHOSPHATE

SMILES

CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O

InChI

InChIKey=GLWHPRRGGYLLRV-XLPZGREQSA-N
InChI=1S/C10H16N5O13P3/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(26-8)4-25-30(21,22)28-31(23,24)27-29(18,19)20/h3,6-8H,2,4H2,1H3,(H,21,22)(H,23,24)(H,12,16,17)(H2,18,19,20)/t6-,7+,8+/m0/s1

HIDE SMILES / InChI

Molecular Formula C10H16N5O13P3
Molecular Weight 507.181
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization.
2010-04-16
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
2010-03-15
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.
2009-12-18
Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
1997-02-04
Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
1996-12-03
Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.
1996-11
The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors.
1996-07
Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity.
1996-06
Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs.
1996-01
Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.
1995-10-06
Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
1995-10
Thiadiazole derivatives: highly potent and specific HIV-1 reverse transcriptase inhibitors.
1995-06-09
Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.
1995-02
The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
1994-11-11
Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
1994-10
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
1994-07
Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
1994-06-21
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
1994-03-04
Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
1993-12-14
Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
1993-12
Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.
1993-12
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
1993-11-26
Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
1993-10
Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.
1993-08
The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptase.
1993-08
Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.
1993-08
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.
1993-07-01
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
1993-07
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
1993-05
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.
1993-04
Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
1993-04
Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents.
1990-06
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
1989-12-29
Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.
1989-12
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
1989-12
Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate.
1989-10
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
1989-05
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
1989-05
Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases.
1989-05
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.
1989-02
An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs.
1989-01-01
Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases.
1989-01
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
1988-11
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
1988-08
Alpha, beta- and beta, gamma-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Correlation between affinity for reverse transcriptase, susceptibility to hydrolysis by phosphodiesterases and anti-retrovirus activity.
1988-06-15
Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta.
1987-10-14
Site-specific mutagenesis of AIDS virus reverse transcriptase.
1987-06-01
Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
1987-03
Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue.
1987-03
Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.
1987-02-15
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:59:48 GMT 2025
Edited
by admin
on Mon Mar 31 18:59:48 GMT 2025
Record UNII
6RGF96R053
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZTTP
Preferred Name English
ZIDOVUDINE TRIPHOSPHATE
Common Name English
3'-AZIDO-3'-DEOXYTHYMIDINE TRIPHOSPHATE
Systematic Name English
3'-AZIDO-3'-DEOXYTHYMIDINE 5'-TRIPHOSPHATE
Systematic Name English
3'-AZIDOTHYMIDINE TRIPHOSPHATE
Systematic Name English
THYMIDINE 5'-(TETRAHYDROGEN TRIPHOSPHATE), 3'-AZIDO-3'-DEOXY-
Common Name English
AZIDOTHYMIDINE TRIPHOSPHATE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID80239053
Created by admin on Mon Mar 31 18:59:48 GMT 2025 , Edited by admin on Mon Mar 31 18:59:48 GMT 2025
PRIMARY
CAS
92586-35-1
Created by admin on Mon Mar 31 18:59:48 GMT 2025 , Edited by admin on Mon Mar 31 18:59:48 GMT 2025
PRIMARY
FDA UNII
6RGF96R053
Created by admin on Mon Mar 31 18:59:48 GMT 2025 , Edited by admin on Mon Mar 31 18:59:48 GMT 2025
PRIMARY
PUBCHEM
72187
Created by admin on Mon Mar 31 18:59:48 GMT 2025 , Edited by admin on Mon Mar 31 18:59:48 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY